Award

Provision of Fasudil Hydrochloride Capsules

UNIVERSITY OF EXETER

This public procurement record has 2 releases in its history.

Award

23 Nov 2021 at 12:10

Tender

15 Jul 2021 at 10:08

Summary of the contracting process

The University of Exeter is conducting a procurement process for the "Provision of Fasudil Hydrochloride Capsules," categorised under medical equipment and pharmaceuticals. The procurement is currently in the award stage, with the value of the contract signed at £815,555. The contract was awarded on 8 November 2021 and pertains to supplying products necessary for a Phase IIa clinical trial likely to be held in the United States and Europe (specifically the UK and Norway). Key compliance standards include Good Manufacturing Practice (GMP) and regulatory requirements of the USP/EP/BP, necessitating that suppliers ensure clinical supplies are released by a certified Quality Person. These procurement opportunities can significantly benefit businesses in the pharmaceutical and healthcare industries, particularly those experienced in drug development, manufacturing, and regulatory compliance. Companies with capabilities in sourcing and supplying medical ingredients, conducting clinical trials, and adhering to stringent quality assurance protocols would be well-positioned to compete for this contract. The tender also represents an opportunity for growth within the clinical supply chain in the UK and Norway, appealing to both large-scale suppliers and specialised service providers in pharmaceuticals.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Provision of Fasudil Hydrochloride Capsules

Notice Description

The University of Exeter requires an end-to-end solution for Fasudil Hydrochloride Capsules. The product will be used as clinical supply for a Phase IIa study. The clinical trial will likely be conducted in the USA and/or Europe (United Kingdom and Norway), therefore all formulation components and finished product must meet the regulatory requirements of USP/EP/BP and any required Norwegian pharmacopeia standards. The supplier must also comply with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) and ensure that all supplies are released for clinical use by a duly certified Quality Person (QP).

Lot Information

Lot 1

The University of Exeter requires an end-to-end solution for Fasudil Hydrochloride Capsules. The product will be used as clinical supply for a Phase IIa study. The clinical trial will likely be conducted in the USA and/or Europe (United Kingdom and Norway), therefore all formulation components and finished product must meet the regulatory requirements of USP/EP/BP and any required Norwegian pharmacopeia standards. The supplier must also comply with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) and ensure that all supplies are released for clinical use by a duly certified Quality Person (QP). The supplier will undertake an evaluation of 3rd party suppliers for the procurement of the Drug Substance (DS) Fasudil Hydrochloride. It is anticipated that approximately 8.5kg of DS will be required for use in Drug Product development and manufacturing activities. This includes approximately 1kg DS for non-GMP activities and 7.5kg DS for GMP activities related to the project. The supplier will perform development activities in order to establish suitable capsule formulations for 20mg and 40mg active dose strengths and matching placebo. These development activities will include the manufacture of up to six development batches at a batch size of approximately 750g -1.5kg. The lead and back-up formulations will be subjected to a short-term stability evaluation. The purpose of this effort is to manufacture sufficient supplies of prototypes to illustrate the likely process for clinical supply, and to prepare samples for accelerated stability testing so that suitable formulations of active and placebo tablets can be identified. To fulfil clinical supply, the CTM active and placebo batches will be manufactured in three separate campaigns. First Campaign: one CTM Placebo batch at approximately 43,000 units one CTM Active 20mg dose strength batch at 6,000 units one CTM Active 40mg strength batch at approximately 40,000 units Second campaign: one CTM Placebo batch at approximately 43,000 units one CTM Active batch at approximately 40,000 units Third campaign: one CTM Placebo batch at approximately 43,000 units one CTM Active batch at approximately 40,000 units Each CTM batch will be bulk packaged, labelled (in English and Norwegian) and shipped to enable delivery of the final QP released batches to the locations requested by Client (anticipated to be in the UK and Norway, 3 or 4 sites in total). The supplier will be responsible for any customs clearance required. The supplier will be required to provide all necessary supporting services including, but not limited to, sourcing materials and the active pharmaceutical ingredient/drug substance, production, storage, labelling, packaging, quality control, qualified person release, packing, transport, loading/unloading, import/export, delivery and waste disposal.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02c838
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/029136-2021
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33000000 - Medical equipments, pharmaceuticals and personal care products

Notice Value(s)

Tender Value
£500,000 £500K-£1M
Lots Value
£500,000 £500K-£1M
Awards Value
Not specified
Contracts Value
£815,555 £500K-£1M

Notice Dates

Publication Date
23 Nov 20214 years ago
Submission Deadline
16 Aug 2021Expired
Future Notice Date
Not specified
Award Date
8 Nov 20214 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
UNIVERSITY OF EXETER
Contact Name
Jodie Underhay
Contact Email
j.underhay@exeter.ac.uk
Contact Phone
Not specified

Buyer Location

Locality
EXETER
Postcode
EX4 4QH
Post Town
Exeter
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK4 Devon
Small Region (ITL 3)
TLK43 Devon CC
Delivery Location
TLK4 Devon

Local Authority
Exeter
Electoral Ward
Duryard and St James
Westminster Constituency
Exeter

Supplier Information

Number of Suppliers
1
Supplier Name

PATHEON

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-02c838-2021-11-23T12:10:23Z",
    "date": "2021-11-23T12:10:23Z",
    "ocid": "ocds-h6vhtk-02c838",
    "initiationType": "tender",
    "tender": {
        "id": "UOE/2021/046/JU",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Provision of Fasudil Hydrochloride Capsules",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33000000",
            "description": "Medical equipments, pharmaceuticals and personal care products"
        },
        "mainProcurementCategory": "goods",
        "description": "The University of Exeter requires an end-to-end solution for Fasudil Hydrochloride Capsules. The product will be used as clinical supply for a Phase IIa study. The clinical trial will likely be conducted in the USA and/or Europe (United Kingdom and Norway), therefore all formulation components and finished product must meet the regulatory requirements of USP/EP/BP and any required Norwegian pharmacopeia standards. The supplier must also comply with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) and ensure that all supplies are released for clinical use by a duly certified Quality Person (QP).",
        "value": {
            "amount": 500000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "The University of Exeter requires an end-to-end solution for Fasudil Hydrochloride Capsules. The product will be used as clinical supply for a Phase IIa study. The clinical trial will likely be conducted in the USA and/or Europe (United Kingdom and Norway), therefore all formulation components and finished product must meet the regulatory requirements of USP/EP/BP and any required Norwegian pharmacopeia standards. The supplier must also comply with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) and ensure that all supplies are released for clinical use by a duly certified Quality Person (QP). The supplier will undertake an evaluation of 3rd party suppliers for the procurement of the Drug Substance (DS) Fasudil Hydrochloride. It is anticipated that approximately 8.5kg of DS will be required for use in Drug Product development and manufacturing activities. This includes approximately 1kg DS for non-GMP activities and 7.5kg DS for GMP activities related to the project. The supplier will perform development activities in order to establish suitable capsule formulations for 20mg and 40mg active dose strengths and matching placebo. These development activities will include the manufacture of up to six development batches at a batch size of approximately 750g -1.5kg. The lead and back-up formulations will be subjected to a short-term stability evaluation. The purpose of this effort is to manufacture sufficient supplies of prototypes to illustrate the likely process for clinical supply, and to prepare samples for accelerated stability testing so that suitable formulations of active and placebo tablets can be identified. To fulfil clinical supply, the CTM active and placebo batches will be manufactured in three separate campaigns. First Campaign: one CTM Placebo batch at approximately 43,000 units one CTM Active 20mg dose strength batch at 6,000 units one CTM Active 40mg strength batch at approximately 40,000 units Second campaign: one CTM Placebo batch at approximately 43,000 units one CTM Active batch at approximately 40,000 units Third campaign: one CTM Placebo batch at approximately 43,000 units one CTM Active batch at approximately 40,000 units Each CTM batch will be bulk packaged, labelled (in English and Norwegian) and shipped to enable delivery of the final QP released batches to the locations requested by Client (anticipated to be in the UK and Norway, 3 or 4 sites in total). The supplier will be responsible for any customs clearance required. The supplier will be required to provide all necessary supporting services including, but not limited to, sourcing materials and the active pharmaceutical ingredient/drug substance, production, storage, labelling, packaging, quality control, qualified person release, packing, transport, loading/unloading, import/export, delivery and waste disposal.",
                "value": {
                    "amount": 500000,
                    "currency": "GBP"
                },
                "contractPeriod": {
                    "durationInDays": 540
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "hasOptions": false,
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                }
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33000000",
                        "description": "Medical equipments, pharmaceuticals and personal care products"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKK4"
                    },
                    {
                        "region": "UKK4"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "submissionMethod": [
            "electronicSubmission",
            "written"
        ],
        "submissionMethodDetails": "https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=38809&B=EXETER",
        "documents": [
            {
                "id": "economic",
                "documentType": "economicSelectionCriteria"
            },
            {
                "id": "technical",
                "documentType": "technicalSelectionCriteria"
            }
        ],
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "coveredBy": [
            "GPA"
        ],
        "tenderPeriod": {
            "endDate": "2021-08-16T12:00:00+01:00"
        },
        "submissionTerms": {
            "languages": [
                "en"
            ]
        },
        "awardPeriod": {
            "startDate": "2021-08-16T12:00:00+01:00"
        },
        "bidOpening": {
            "date": "2021-08-16T12:00:00+01:00"
        },
        "hasRecurrence": false
    },
    "parties": [
        {
            "id": "GB-FTS-1655",
            "name": "University of Exeter",
            "identifier": {
                "legalName": "University of Exeter",
                "id": "RC000653"
            },
            "address": {
                "streetAddress": "Northcote House",
                "locality": "Exeter",
                "region": "UKK4",
                "postalCode": "EX4 4QH",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Jodie Underhay",
                "email": "j.underhay@exeter.ac.uk",
                "url": "https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=38809&B=EXETER"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "http://www.exeter.ac.uk",
                "buyerProfile": "https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/53042",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "09",
                        "description": "Education"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-92",
            "name": "Royal Courts of Justice",
            "identifier": {
                "legalName": "Royal Courts of Justice"
            },
            "address": {
                "locality": "London",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        },
        {
            "id": "GB-FTS-35430",
            "name": "Patheon UK Limited",
            "identifier": {
                "legalName": "Patheon UK Limited",
                "id": "3764421"
            },
            "address": {
                "streetAddress": "Patheon Building, Kingfisher Drive, Covingham",
                "locality": "Swindon",
                "region": "UKK1",
                "postalCode": "SN3 5BZ",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "jon.faulkes@thermofisher.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-1655",
        "name": "University of Exeter"
    },
    "language": "en",
    "awards": [
        {
            "id": "029136-2021-1-1",
            "relatedLots": [
                "1"
            ],
            "title": "Provision of Fasudil Hydrochloride Capsules",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-35430",
                    "name": "Patheon UK Limited"
                }
            ]
        }
    ],
    "contracts": [
        {
            "id": "029136-2021-1-1",
            "awardID": "029136-2021-1-1",
            "title": "Provision of Fasudil Hydrochloride Capsules",
            "status": "active",
            "value": {
                "amount": 815555,
                "currency": "GBP"
            },
            "dateSigned": "2021-11-08T00:00:00Z"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 4
            },
            {
                "id": "2",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 4
            }
        ]
    }
}